- #678 Satish Waman Wagh ₹4,700 Cr

About Supriya Medi-Chem Private Limited
Data last updated:
Supriya Medi-Chem Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2011 and has been in existence for over 15 years.
Its director Satish Waman Wagh is #678 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2011PTC224367. Its GSTIN is 27AATCS7780D1ZQ (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Smita Satish Wagh and Satish Waman Wagh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 207 / 208 Udyog Bhavan Sonawala Road Goregaon ( East), Mumbai, Maharashtra, India – 400063.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website supriyalifescience.com.
Company details
Recognitions & Rankings of Supriya Medi-Chem
Contact details
Supriya Medi-Chem Private Limited's registered office is in Mumbai, Maharashtra. Its website is supriyalifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address207 / 208 Udyog Bhavan Sonawala Road Goregaon ( East), Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Supriya Medi-Chem Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Supriya Medi-Chem Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Supriya Medi-Chem Private Limited, buy the company report.
Board of directors of Supriya Medi-Chem Private Limited
Supriya Medi-Chem has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smita Satish Wagh Also directs: Supriya Lifescience Limited | Director | 24 Nov 2011 | 14 Years 11 Months | Current |
| Satish Waman Wagh Also directs: Supriya Lifescience Limited, Sachin Industries Limited, Global Gsa Services India Private Limited and 3 more | Director | 24 Nov 2011 | 14 Years 11 Months | Current |
Auditor
Supriya Medi-Chem Private Limited is audited by P.KMUTHA&COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.KMUTHA&COMPANY | FY 2023 | 106728W |
Shareholding
The shareholding of Supriya Medi-Chem Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Supriya Medi-Chem Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Supriya Medi-Chem Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supriya Medi-Chem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Supriya Medi-Chem has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AATCS7780D1ZQ | Maharashtra | Active | 11 Apr 2018 |
To see the full GST registrations and return filing status of Supriya Medi-Chem Private Limited, buy the company report.
Recent activity
Supriya Medi-Chem Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Satish Waman Wagh was appointed as Director on 24 Nov 2011.
News
Frequently asked questions
Supriya Medi-Chem is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2011 (15+ years old) and is registered under CIN U74999MH2011PTC224367.
Supriya Medi-Chem has 2 current directors:
- Smita Satish Wagh - Director
- Satish Waman Wagh - Director
The latest financial statements of Supriya Medi-Chem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Supriya Medi-Chem is 27AATCS7780D1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Supriya Medi-Chem is U74999MH2011PTC224367. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supriya Medi-Chem was incorporated on 24 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Satish Waman Wagh was appointed as Director on 24 Nov 2011. Smita Satish Wagh was appointed as Director on 24 Nov 2011.
Supriya Medi-Chem can be reached through the website supriyalifescience.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Supriya Medi-Chem is at 207 208 Udyog Bhavan Sonawala Road Goregaon East, Mumbai, Maharashtra, India – 400063.
Supriya Medi-Chem operates in the pharma industry, in the drug formulation and development segment.

